BRANDED DRUG - PHARMACEUTICALS
Solicitation number E60PH-22BRND/A
Publication date
Closing date and time 2022/06/17 14:00 EDT
Last amendment date
Description
Trade Agreement: CETA/WTO-AGP/CPTPP/CFTA/FTAs with Peru/Colombia/Panama/Korea/UK Tendering Procedures: Generally only one firm has been invited to bid Non-Competitive Procurement Strategy: Exclusive Rights Comprehensive Land Claim Agreement: No Vendor Name and Address: VARIOUS PHARMACEUTICALS SUPPLIERS VARIOUS VARIOUS Ontario Canada A1A1A1 Nature of Requirements: 1. Definition of the requirement PSPC proposes to establish contract pricing with manufacturers of patent protected pharmaceuticals on behalf of the Federal/Provincial/Territorial (F/P/T) Group Purchasing Program for Drugs and Vaccines on an as-and-when requested basis. 2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements) Any interested supplier must demonstrate by way of a statement of capabilities that its pharmaceutical product meets the following requirements: a) Must have a valid DIN number; b) Must have the same active pharmaceutical ingredient (API) and strength as indicated in the list below. c) Must be able to deliver on a national scale. 3. Applicability of the trade agreement(s) to the Canadian Free Trade Agreement (CFTA), the Canada - Korea Free Trade Agreement, the Canada - Chile Free Trade Agreement (CCFTA), the Canada - Colombia Free Trade Agreement, the Canada - Honduras Free Trade Agreement, the Canada - Panama Free Trade Agreement, the Canada - Peru Free Trade Agreement (CPFTA), the Canada - Ukraine Free Trade Agreement (CUFTA), the Canada - European Union Comprehensive Economic and Trade Agreement (CETA), the Canada - United Kingdom Trade Continuity Agreement (Canada-UK TCA), the Revised World Trade Organization Agreement on Government Procurement (WTO-AGP), and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), 4. Justification for the Pre-Identified Supplier This requirement is being negotiated with the following suppliers as they are the only known suppliers capable of providing the drugs listed at the bottom of this document. The suppliers are: AA Pharma Inc., AbbVie Canada, ASM Canada, Astra Zeneca Canada, Bayer Canada, BGP Pharma ULC, Covis Pharma Canada Ltd., Eli Lilly Canada, Fresenius-Kabi Canada, GSK Consumer Health, Hikma Canada Ltd., Johnson & Johnson Canada, Leo Pharma Canada, Lundbeck Canada Inc., Lupin Pharma Canada, Mallinckrodt Canada Inc., Merck Canada, Novartis Pharmaceuticals Canada Inc., Novo Nordisk Canada Inc., Organon Canada Inc., Otsuka Canada Pharma, Pfizer Canada, Roche Canada, Sanofi-Aventis Canada Inc., SteriMax Inc., Takeda Canada Inc., Viiv Healthcare Canada. 5. Government Contracts Regulations Exception(s) The following exception(s) to the Government Contracts Regulations is invoked for this procurement under subsection 6(d) as only one supplier is capable of performing the work. 6. Period of the proposed contract or delivery date From August 1, 2022 to June 30, 2023, with an option to extend the contract period for two additional one-year periods from July 1, 2023 to June 30, 2024 and July 1, 2024 to June 30, 2025. 7. Closing date for a submission of a statement of capabilities The closing date and time for accepting statements of capabilities is June 16, 2022 at 2:00 p.m. 8. Inquiries and statements of capabilities are to be directed to: Julia Summers Telephone: (613) 298-2724 E-mail: julia.summers@tpsgc-pwgsc.gc.ca LIST OF ITEMS ABILIFY MAINTENA VL 300MG ABILIFY MAINTENA VL 400MG ACETYLCYST VL 200MG/ML 10X30ML ADVAIR DISKUS 100MCG 60DS ADVAIR DISKUS 250MCG 60DS ADVAIR DISKUS 500MCG 60DS ADVAIR MDI INHALER 125MCG 120DS ADVAIR MDI INHALER 250MCG 120DS AERIUS ALRGY TB 5MG BX 20 AERIUS ALRGY TB 5MG BX 30 ANDROGEL PUMP 1% 2x60 DS ANDROGEL SACHET 1% 30x2.5G ANDROGEL SACHET 1% 30x5G ASMANEX TWISTHALER 200MCG 60 ASMANEX TWISTHALER 400MCG 60 ATROPINE SY0.1MG/ML 10X10ML AVENTYL CAPS 10MG 100 AVENTYL CAPS 25MG 100 BASAGLAR KPEN 100U/ML 5X3ML BENADRYL LIQ CHLD B/GUM 100mL BICILLIN L A SYR 10X2ML BOTOX VL 100U 1 BREO ELLIPTA INH 100MCG 30DS BREO ELLIPTA INH 200MCG 30DS BRILINTA TB 90MG HOP 60 CALC CHLOR ANSYR 10% 10X10ML CALCIUM CHLORIDE SYR 10% L 10X10ML CALC GLUC 100MG/ML 25X10ML CANESTEN COMBIPACK TRMT 3DAY CEFTIN SUSP 125MG/5ML 100ML CIPRODEX OTIC SUSP 7.5ML CLAVULIN 400 SUSP 70ML CLOPIXOL DEP 200MG/ML 10X1ML COMBANTRIN TB 125MG 12 COSENTYX AI SSR 150MG 2X1ML DALACIN C PALMITATE 100ML DEPO PROVERA CONT INJ SYR 150MG/ML 1ML 9737611 US DEPO PROVERA SUSP 150MG/ML 1ML DEXILANT CP DR 30MG 90 DEXILANT CP DR 60MG 90 DIPROSALIC OINT 50G DOVATO TB 50MG/300MG 30 DOVOBET GEL 0.5MG/50MCG 80G DOVOBET OINT 0.5MG/50MCG 120G ENSTILAR 50MCG/0.5MG 60G EPINEP SYR.1MG 1 1/2L10X10ML FLOVENT DISK PD 250MCG FLOVENT HFA 125MCG/DS 120DS FLOVENT HFA 250MCG/DS 120DS FLUANXOL DEPOT100MG/ML10X1ML FORXIGA TB 10MG BLST 3X10 FORXIGA TB 5MG BLST 3X10 FOMEPIZOLE FOR INJ 2X1.5ML GLUCAGON RDNA SYR 1MG 1X1ML HUMALOG CARTRIDGE 100U/ML 5X3ML HUMALOG KW 100U/ML 5X3ML HUMIRA PN 40MG/0.8ML 2X0.8ML HUMIRA PREFILLED SYR 40MG/0.8ML HUMULIN N CART 100U/ML 5X3ML HUMULIN N VL 100U/ML 10ML HUMULIN R CART 100U/ML 5X3ML IMITREX NAS SP 20MG 1X2 INTUNIV XR TB 1MG 100 INTUNIV XR TB 2MG 100 INTUNIV XR TB 3MG 100 INTUNIV XR TB 4MG 100 ISENTRESS TB 400MG 60 JANUMET TB 50MG/1000MG 60 JANUVIA TB 100MG 100 JANUVIA TB 50MG 30 JULUCA TB 50MG/25MG 30 KADIAN CAPS 20MG 100 KADIAN CAPS 50MG 100 KADIAN CAPS 100MG 50 KADIAN CAPS 10MG 100 KALETRA TB 200-50MG 120 KWELLADA-P 5% PERM LOT 100ML LAMISIL CR 1% 30G LANTUS CART 100IU/ML 5X3ML LANTUS SOLOSTAR 5X3ML LEVEMIR PENFIL100U/ML 5X3ML LOVENOX PROT NDL 100MG10X1ML LOVENOX SYR 40MG/0.4ML LOVENOX VL 100MG/ML LUPRON DEPOT INJ KIT 3.75MG LUPRON DEPOT INJ KIT 11.25MG LUPRON DEPOT INJ KIT 22.5MG1 LUPRON DEPOT INJ KIT 7.5MG 1 MAVIRET TB 100/40MG BLST 84 METHADOSE N/DYE S/F UNFLV 1L METHOPRAZINE TB 25MG 100 MEZAVANT TB ER 1.2G 120 MIRENA IUS 1 NIX CR DERMAL 5% 30G NIX CR RIN LICE 1% 59ML NORVIR TB 100MG 30 NOVOLIN GE NPH CART 5X3ML NOVORAPID CART100U/ML 5X3ML NUVARING VAG RING OCREVUS INJ VL 30MG/ML 10ML OZEMPIC 4MG/PEN PRE FILLED 1MG/DOSE 3ML OZEMPIC PRE FLD 1X2MG1.5ML PEN VK TB 300MG 100 PEN VK TB 300MG 1000 PROTOPIC OINT 0.03% 60G PROTOPIC OINT 0.10% 60G PULMICORT NEB 0.25MG 20X2ML PULMICORT NEB 0.5MG 20X2ML R&C SHP&CND W/NIT COMB 50ML REACTINE RG TB 5MG RESTORALAX SACHET 17G REXULTI TB 0.5MG 30 REXULTI TB 1MG 30 ROBAXIN TB 500MG 50 SATIVEX SP 3X10ML SAXENDA 6MG/ML PNPREFIL5X3ML SEEBRI BREEZHALER 50MCG BLST 1 DEVICE 3X10 SINEQUAN CAPS 100MG 100 SINEQUAN CAPS 50MG 100 SINEQUAN CAPS 75MG 100 SULFATRIM DS TB 800-160MG500 SYMBICORT TURBU 100MCG 120DS SYMBICORT TURBU 200MCG 120DS SYNTHROID TB 100MCG 90 SYNTHROID TB 112MCG 90 SYNTHROID TB 125MCG 90 SYNTHROID TB 137MCG 90 SYNTHROID TB 150MCG 90 SYNTHROID TB 175MCG 90 SYNTHROID TB 200MCG 90 SYNTHROID TB 25MCG 90 SYNTHROID TB 50MCG 90 SYNTHROID TB 75MCG 90 SYNTHROID TB 88MCG 90 TASIGNA CAPS 200MGBL 4X(7X4) TIVICAY TB 50MG 30 TNKASE VL 50MG 1X50MG TOUJEO SOLOSTAR PREFILLED PEN 300UNIT/ML 5 TOVIAZ TB 8MG 30 TRESIBA FLEXTO 100U/ML 5X3ML TRESIBA FLEXTO 200U/ML 3X3ML TRINTELLIX TB 10MG 28 TRINTELLIX TB 20MG 28 TRINTELLIX TB 5MG 28 TRIUMEQ TB 600/50/300MG UD30 TYLENOL CHILD BANANA STRAWBERRY 100ML TYLENOL CHILD DYE FREE BERRY 100ML TYLENOL SUSP CHILD BUBBLE GUM 100ML TYLENOL SUSP DYE FREE CHERRY 100ML TYLENOL SUSP GRAPE 160MG/5ML 100ML TYLENOL SUSP LIQ CHILD BERRY 2X100ML TYLENOL SUSP160MG/5MLGP100ML ULTIBRO BREEZHALER .11/.05MG 3X10 VICTOZA PRE FILLED 3X3.0ML VOLTAREN EMUL BACK/MUSC 30G VOLTAREN EMUL BACK/MUSC 50G VOLTAREN EMUL BACK/MUSC 100G VOLTAREN EMULGEL 12H EXTRA STRENGTH 30G VOLTAREN EMULGEL EXTRA STRENGTH 100G VOLTAREN EMULGEL JOINT PAIN 120G VOLTAREN EMULGEL X-STR JOINT PAIN 100G VYVANSE CAPS 10MG 100 VYVANSE CAPS 20MG 100 VYVANSE CAPS 30MG 100 VYVANSE CAPS 40MG 100 VYVANSE CAPS 50MG 100 VYVANSE CAPS 60MG 100 VYVANSE CAPS 70MG 100 XARELTO TB 10MG 50 XARELTO TB 15MG 1X90 XARELTO TB 20MG 90 XELJANZ TB 5MG 60 XOLAIR PFS SYR 150MG/ML 1 YASMIN TB 21 YASMIN TB 28 ZAXINE TB 550MG 60 Delivery Date: 01/08/2022 You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above. An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process. Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements. The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page. The Crown retains the right to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada.
Contract duration
Refer to the description above for full details.
Trade agreements
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Panama Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Peru Free Trade Agreement (CPFTA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Contact information
Contracting organization
- Organization
-
Public Works and Government Services Canada
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Summers(ph885), Julia
- Phone
- (613) 298-2724 ( )
- Email
- julia.summers@tpsgc-pwgsc.gc.ca
- Fax
- () -
- Address
-
Terrasses de la Chaudière 5th Floor
10 Wellington StreetGatineau, Quebec, K1A 0S5
Buying organization(s)
- Organization
-
Public Works and Government Services Canada
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
Bidding details
Details for this tender opportunity are provided in the Description tab.
Please contact the contracting officer to get the full solicitation documentation, access information on how to bid, or if you have any questions regarding this tender opportunity.
Note that there may be fees to access the documents or bid. These should be outlined in the Description tab.
We recommend that you contact the contracting officer as soon as possible, as there may be deadlines for receiving questions.